Stem cell transplants to be used in treating Crohn’s diseaseAllbiopro2018-08-08T00:19:00+09:008월 8th, 2018|
A Roundup of Major Q2 Reports: Biogen, AstraZeneca, Pfizer and MoreAllbiopro2018-08-07T01:52:16+09:008월 7th, 2018|
Pharma and Biotech Companies Provide Top Salaries: SurveyAllbiopro2018-08-07T01:51:51+09:008월 7th, 2018|
Ovid’s Angelman Syndrome Therapy Hits Prespecified Endpoint Phase II Trial, Shares Drop SignificantlyAllbiopro2018-08-07T01:51:03+09:008월 7th, 2018|
Ironwood dumps AstraZeneca gout med Zurampic—and lays off 125 in the processAllbiopro2018-08-07T01:50:37+09:008월 7th, 2018|
Regeneron and bluebird bio Team Up to Develop Cell Therapies for CancerAllbiopro2018-08-07T01:50:12+09:008월 7th, 2018|
AbbVie, Roche and Pfizer the worst patent ‘offenders,’ says nonprofitAllbiopro2018-08-07T01:49:47+09:008월 7th, 2018|
FDA Action Alert: DURECT, Vertex, Arbutus & Alnylam, and RegeneronAllbiopro2018-08-07T01:49:22+09:008월 7th, 2018|
Acorda inks Ampyra generic settlements as it waits for patent appeal newsAllbiopro2018-08-07T01:48:57+09:008월 7th, 2018|
Pharma reps get more respect from doctors in Japan. What’s the takeaway for U.S. reps?Allbiopro2018-08-07T01:48:32+09:008월 7th, 2018|
Look who’s talking: FDA chief Scott Gottlieb churns out statements by the dozenAllbiopro2018-08-07T01:48:06+09:008월 7th, 2018|
One more dose: Sanofi pushes importance of forgotten second dose of meningitis vaccineAllbiopro2018-08-07T01:47:41+09:008월 7th, 2018|
Pain Therapeutics CEO Lashes Out as FDA Rejects Company’s RemoxyAllbiopro2018-08-07T01:47:15+09:008월 7th, 2018|
Pain Therapeutics hit with yet another CRL, plots ‘reorganization,’ Alzheimer’s pivotAllbiopro2018-08-07T01:46:49+09:008월 7th, 2018|
Alzheon Researchers Identify Brain Molecule that Inhibits Formation of Alzheimer’s ProteinsAllbiopro2018-08-07T01:46:24+09:008월 7th, 2018|
Ovid posts results from midstage rare disease test, plots registrational pathAllbiopro2018-08-07T01:45:58+09:008월 7th, 2018|
